Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
641 A pilot study of a DNAJB1-PRKACA fusion kinase peptide vaccine combined with nivolumab and ipilimumab for patients with fibrolamellar hepatocellular carcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
